Introduction
Semax and Selank are both synthetic peptides developed at the Russian Academy of Sciences with decades of clinical use in Russia and neighboring countries. Semax is derived from ACTH(4-10) and primarily enhances cognitive function through BDNF upregulation, while Selank is based on the immunopeptide tuftsin and provides anxiolytic effects through GABAergic modulation. Though both are classified as nootropics, their mechanisms and primary applications differ significantly.
Mechanism of Action Comparison
Semax is a heptapeptide analog of the ACTH(4-10) fragment (Met-Glu-His-Phe-Pro-Gly-Pro) that crosses the blood-brain barrier to upregulate BDNF (brain-derived neurotrophic factor) and trkB receptor expression. It enhances serotonergic and dopaminergic neurotransmission, increases attention and memory consolidation, and provides neuroprotective effects against oxidative stress and ischemic damage[1].
Selank is a heptapeptide analog of tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro) with anxiolytic properties mediated through modulation of GABAergic neurotransmission. It influences enkephalin expression and metabolism, affects monoamine neurotransmitter balance, and modulates IL-6 expression. Unlike benzodiazepines, Selank produces anxiolysis without sedation, cognitive impairment, or dependence[2].
Key Differences
| Feature | Semax | Selank |
|---|---|---|
| Parent Molecule | ACTH(4-10) | Tuftsin |
| Primary Effect | Cognitive enhancement | Anxiolysis |
| BDNF Upregulation | Strong | Moderate |
| Anxiolytic Activity | Mild secondary effect | Primary effect |
| Dopamine Modulation | Significant | Minimal |
| GABA Enhancement | Minimal | Significant |
| Immune Modulation | Mild | Moderate (tuftsin-derived) |
| Administration | Intranasal | Intranasal |
Research Applications
Semax is investigated in stroke recovery, cognitive decline, ADHD, traumatic brain injury, and neurodegenerative disease research where BDNF upregulation and neuroprotection are key endpoints. Selank is studied in anxiety disorders, stress-related cognitive impairment, immunomodulation, and conditions where non-sedating anxiolysis is desired. Both peptides are increasingly studied in combination for protocols addressing both cognitive and emotional dimensions of brain health.
Which to Choose for Your Research?
For cognitive enhancement, neuroprotection, or BDNF-focused research, Semax is the more targeted choice. For anxiety research, stress resilience, or GABAergic modulation studies, Selank provides a cleaner pharmacological tool. Many researchers use both peptides together, as their mechanisms are complementary rather than overlapping. Enhanced forms such as N-Acetyl Semax Amidate and N-Acetyl Selank Amidate offer improved stability and potency for research applications.
